These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22371183)

  • 1. Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients.
    Santamaría C; Muntión S; Rosón B; Blanco B; López-Villar O; Carrancio S; Sánchez-Guijo FM; Díez-Campelo M; Alvarez-Fernández S; Sarasquete ME; de las Rivas J; González M; San Miguel JF; Del Cañizo MC
    Haematologica; 2012 Aug; 97(8):1218-24. PubMed ID: 22371183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
    Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome.
    Zhao Y; Wu D; Fei C; Guo J; Gu S; Zhu Y; Xu F; Zhang Z; Wu L; Li X; Chang C
    Haematologica; 2015 Feb; 100(2):194-204. PubMed ID: 25361944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dicer and Drosha expression in patients with nephrotic syndrome.
    Hejazian SM; Rahbar Saadat Y; Bahmanpour Z; Hosseiniyan Khatibi SM; Ardalan M; Zununi Vahed S
    Biofactors; 2020 Jul; 46(4):645-652. PubMed ID: 32412691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells.
    Guo J; Zhao Y; Fei C; Zhao S; Zheng Q; Su J; Wu D; Li X; Chang C
    Cell Death Dis; 2018 May; 9(5):512. PubMed ID: 29724992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the Effect of 3'-UTR Variants in
    Bug DS; Tishkov AV; Moiseev IS; Petukhova NV
    Curr Issues Mol Biol; 2021 Jul; 43(2):605-617. PubMed ID: 34287278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma.
    Guo X; Liao Q; Chen P; Li X; Xiong W; Ma J; Li X; Luo Z; Tang H; Deng M; Zheng Y; Wang R; Zhang W; Li G
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):49-56. PubMed ID: 21953080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia.
    Raaijmakers MH; Mukherjee S; Guo S; Zhang S; Kobayashi T; Schoonmaker JA; Ebert BL; Al-Shahrour F; Hasserjian RP; Scadden EO; Aung Z; Matza M; Merkenschlager M; Lin C; Rommens JM; Scadden DT
    Nature; 2010 Apr; 464(7290):852-7. PubMed ID: 20305640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas.
    Prodromaki E; Korpetinou A; Giannopoulou E; Vlotinou E; Chatziathanasiadou Μ; Papachristou NI; Scopa CD; Papadaki H; Kalofonos HP; Papachristou DJ
    Cell Oncol (Dordr); 2015 Aug; 38(4):307-17. PubMed ID: 26227789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.
    Czubak K; Lewandowska MA; Klonowska K; Roszkowski K; Kowalewski J; Figlerowicz M; Kozlowski P
    Oncotarget; 2015 Sep; 6(27):23399-416. PubMed ID: 26156018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
    Díaz-García CV; Agudo-López A; Pérez C; López-Martín JA; Rodríguez-Peralto JL; de Castro J; Cortijo A; Martínez-Villanueva M; Iglesias L; García-Carbonero R; Fresno Vara JA; Gámez-Pozo A; Palacios J; Cortés-Funes H; Paz-Ares L; Agulló-Ortuño MT
    Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer.
    Sand M; Gambichler T; Skrygan M; Sand D; Scola N; Altmeyer P; Bechara FG
    Cancer Invest; 2010 Jul; 28(6):649-53. PubMed ID: 20210522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of microRNA biogenesis machinery: Drosha, DGCR8 and Dicer in multiple sclerosis patients.
    Jafari N; Shaghaghi H; Mahmoodi D; Shirzad Z; Alibeiki F; Bohlooli S; Dogaheh HP
    J Clin Neurosci; 2015 Jan; 22(1):200-3. PubMed ID: 25439752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer.
    Torres A; Torres K; Paszkowski T; Jodłowska-Jędrych B; Radomański T; Książek A; Maciejewski R
    Tumour Biol; 2011 Aug; 32(4):769-76. PubMed ID: 21559780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
    Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
    Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and Clinical Significance of ANXA1 and DICER1 in Myelodysplastic Syndromes.
    Wu W; Wan C; Xie Q; Liang X; Wen J; Liu Z
    J Coll Physicians Surg Pak; 2020 Dec; 30(12):1291-1296. PubMed ID: 33397055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of microRNA processing enzymes Drosha and Dicer in gestational diabetes mellitus.
    Rahimi G; Jafari N; Khodabakhsh M; Shirzad Z; Dogaheh HP
    Gynecol Endocrinol; 2015 Feb; 31(2):156-9. PubMed ID: 25295740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
    Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
    Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dicer, Drosha, and outcomes in patients with ovarian cancer.
    Merritt WM; Lin YG; Han LY; Kamat AA; Spannuth WA; Schmandt R; Urbauer D; Pennacchio LA; Cheng JF; Nick AM; Deavers MT; Mourad-Zeidan A; Wang H; Mueller P; Lenburg ME; Gray JW; Mok S; Birrer MJ; Lopez-Berestein G; Coleman RL; Bar-Eli M; Sood AK
    N Engl J Med; 2008 Dec; 359(25):2641-50. PubMed ID: 19092150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated expression of dicer and drosha in breast cancer.
    Yan M; Huang HY; Wang T; Wan Y; Cui SD; Liu ZZ; Fan QX
    Pathol Oncol Res; 2012 Apr; 18(2):343-8. PubMed ID: 21898071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.